Rationale Psychedelic research continues to garner significant public and scientific interest
with a growing number of clinical studies examining a wide range of conditions and …

Post‐traumatic stress disorder (PTSD) is arguably the most common psychiatric disorder to
arise after exposure to a traumatic event. Since its formal introduction in the DSM‐III in 1980 …

Atrophy of neurons in the prefrontal cortex (PFC) plays a key role in the pathophysiology of
depression and related disorders. The ability to promote both structural and functional …

Background Posttraumatic stress disorder is a prevalent mental health condition with
substantial impact on daily functioning that lacks sufficient treatment options. Here we …

Background Post-traumatic stress disorder (PTSD) is prevalent in military personnel and first
responders, many of whom do not respond to currently available treatments. This study …

There is growing interest in the therapeutic utility of psychedelic substances, like psilocybin,
for disorders characterized by distortions of the self-experience, like depression …

Rationale Posttraumatic stress disorder (PTSD) is a chronic condition that has wide-ranging
negative effects on an individual's health and interpersonal relationships. Treatments with …

After a two-decade hiatus in which research on psychedelics was essentially halted,
placebo-controlled clinical trials of psychedelic-assisted therapy for mental health conditions …

Introduction: Small-scale clinical studies with psychedelic drugs have shown promising
results for the treatment of several mental disorders. Before psychedelics become registered …

Introduction Interest in the use of psychedelic substances for the treatment of mental
disorders is increasing. Processes that may affect therapeutic change are not yet fully …